These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4680880)

  • 1. [Use of proteolyic enzymes and nucleases in the complex treatment of acute and chronic odontogenic inflammatory processes of the maxillofacial region].
    Korchak LF
    Zh Ushn Nos Gorl Bolezn; 1972; (3):75-80. PubMed ID: 4680880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of proteolytic enzymes in the treatment of acute suppurative diseases of the maxillo-facial area].
    Protasevich AI
    Vestn Khir Im I I Grek; 1969 Mar; 102(3):83-5. PubMed ID: 5358819
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotics and proteoalytic enzymes in the therapy of acute odontogenic osteomyelitis].
    Kaplun MS; Protasevich AI; Orlov VS; Mavlianov AN
    Vestn Khir Im I I Grek; 1969 Dec; 103(12):58-9. PubMed ID: 5379046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complex therapy of purulent inflammatory diseases of the soft tissues of the face and jaw, using prodigiosan].
    Tsepov LM
    Stomatologiia (Mosk); 1975; 54(2):28-31. PubMed ID: 1055482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of proteolytic enzymes in treatment of suppurative-inflammatory processes in children].
    Ali-Zade AM; Salmanov SK; Lemberanskaia SD; Babaeva ZKh; Kerimov NG
    Vestn Khir Im I I Grek; 1973 Jan; 109(1):133-5. PubMed ID: 4712709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific immunotherapy in the overall treatment of odontogenic inflammatory diseases].
    Biberman IaM
    Stomatologiia (Mosk); 1976; 55(4):30-3. PubMed ID: 1071504
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan].
    Zakson ML; Bordonos VG
    Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of thymalin in the prophylaxis and treatment of infectious-inflammatory diseases of the maxillofacial region].
    Solov'ev MM; Alekhova TM; Sysoeva EN; Morozov VG; Khavinson VKh
    Vestn Khir Im I I Grek; 1981 Dec; 127(12):6-11. PubMed ID: 7340043
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of purulent wounds of the maxillofacial region in elderly and senile patients].
    Grigorchik IuF
    Stomatologiia (Mosk); 1972; 51(3):81-2. PubMed ID: 4506917
    [No Abstract]   [Full Text] [Related]  

  • 13. [Enzyme therapy of patients with pyo-inflammatory disease of maxillofacial area].
    Minaev SV; Ibragimov OR; Zelenskiĭ VA; Minaeva NV
    Voen Med Zh; 2007 Nov; 328(11):25-7, 96. PubMed ID: 18306709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of alginic acid-based preparations for treating suppurative wounds of the maxillofacial area and neck].
    Ushakov RV; Dugarov BD; Iakubovich VS; Komissarova AL; Shargorodskiĭ VM
    Stomatologiia (Mosk); 1991; (5):46-7. PubMed ID: 1724711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Supersorbicid in comprehensive treatment of acute pyoinflammatory processes in maxillofacial region].
    Eshbadalov KhIu
    Stomatologiia (Mosk); 2005; 84(2):36-7. PubMed ID: 15798751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzyme therapy as a physiologically based method of treating acute suppurative diseases of the soft tissues].
    Gostishchev VK; Dzhalilov NG
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):73-6. PubMed ID: 5407846
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of chlorhexidine effectiveness in treating acute inflammatory processes of the maxillofacial region].
    Gapanenko TG; Pecherkina SA; Kislykh FI; Dudin AB
    Stomatologiia (Mosk); 1983; 62(1):41-3. PubMed ID: 6572436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.